Limits...
International Clinical Trial Day and clinical trials in Ethiopia and Africa.

Fekadu A, Teferra S, Hailu A, Gebre-Mariam T, Addissie A, Deressa W, Yimer G, Reja A - Trials (2014)

Bottom Line: Low income countries like Ethiopia are underrepresented in clinical research.However, administrative capacity, research infrastructure as well as financial support remain weak.There is a need for enhanced university-industry linkage and translation of research findings into locally relevant evidence.

View Article: PubMed Central - PubMed

Affiliation: Department of Psychiatry, School of Medicine, College of Health Sciences, Addis Ababa University, Zambia Street, PO Box 9086, Addis Ababa, Ethiopia. abe.wassie@kcl.ac.uk.

ABSTRACT
Low income countries like Ethiopia are underrepresented in clinical research. As a major public commitment to clinical research, Ethiopia celebrated the International Clinical Trial Day (ICTD) for the first time on 20 May 2014 under the auspices of Addis Ababa University. The motto for the day was 'Clinical Trials for Excellence in Patient Care'. The celebration offered an opportunity to inform academic staff, researchers, students and the leadership about clinical trials being conducted and to discuss the future of clinical trials in the country. Although clear challenges to the conduct of trials abound, clinical trials registered from Ethiopia in trial registration databases is increasing. Cross-country collaborations, international funding support, motivation of academic staff to conduct clinical trials and the commitment and engagement of the leadership in research are all improving. The overall impact of clinical trials is also encouraging. For example, some of the trials conducted in Ethiopia have informed treatment guidelines. However, administrative capacity, research infrastructure as well as financial support remain weak. There is a need for enhanced university-industry linkage and translation of research findings into locally relevant evidence. Ethiopia, as well as the whole of Africa, has an unparalleled opportunity to lead the way in clinical trials, given its prospect of development and the need to have locally relevant evidence for its growing population. In this commentary we reflect on the celebration of ICTD, the status and opportunities for conducting clinical trials and the way forward for facilitating clinical trials in Ethiopia and Africa.

Show MeSH
Proportion of clinical trials conducted in specific subject or disease area in Ethiopia (N = 59). Based on data available at Clinicaltrials.gov (on 28 June 2014).
© Copyright Policy - open-access
Related In: Results  -  Collection

License 1 - License 2
getmorefigures.php?uid=PMC4300613&req=5

Fig4: Proportion of clinical trials conducted in specific subject or disease area in Ethiopia (N = 59). Based on data available at Clinicaltrials.gov (on 28 June 2014).

Mentions: A Strength, Weakness, Opportunity and Threat (SWOT) analysis matrix is presented in FigureĀ 4. The challenges of conducting clinical trials in Ethiopia and other African countries partly relate to the unique requirements of clinical trials, but there are broader challenges that have applicability to conducting research in general. These include lack of appropriate infrastructure, for example space, supplies and maintenance; weak administrative capacity; lower prioritization of research in academic institutions given the need to produce a university educated work force; limited university-industry linkage; limited sources of funding; and the lack of equitable incentives for researchers.Figure 4


International Clinical Trial Day and clinical trials in Ethiopia and Africa.

Fekadu A, Teferra S, Hailu A, Gebre-Mariam T, Addissie A, Deressa W, Yimer G, Reja A - Trials (2014)

Proportion of clinical trials conducted in specific subject or disease area in Ethiopia (N = 59). Based on data available at Clinicaltrials.gov (on 28 June 2014).
© Copyright Policy - open-access
Related In: Results  -  Collection

License 1 - License 2
Show All Figures
getmorefigures.php?uid=PMC4300613&req=5

Fig4: Proportion of clinical trials conducted in specific subject or disease area in Ethiopia (N = 59). Based on data available at Clinicaltrials.gov (on 28 June 2014).
Mentions: A Strength, Weakness, Opportunity and Threat (SWOT) analysis matrix is presented in FigureĀ 4. The challenges of conducting clinical trials in Ethiopia and other African countries partly relate to the unique requirements of clinical trials, but there are broader challenges that have applicability to conducting research in general. These include lack of appropriate infrastructure, for example space, supplies and maintenance; weak administrative capacity; lower prioritization of research in academic institutions given the need to produce a university educated work force; limited university-industry linkage; limited sources of funding; and the lack of equitable incentives for researchers.Figure 4

Bottom Line: Low income countries like Ethiopia are underrepresented in clinical research.However, administrative capacity, research infrastructure as well as financial support remain weak.There is a need for enhanced university-industry linkage and translation of research findings into locally relevant evidence.

View Article: PubMed Central - PubMed

Affiliation: Department of Psychiatry, School of Medicine, College of Health Sciences, Addis Ababa University, Zambia Street, PO Box 9086, Addis Ababa, Ethiopia. abe.wassie@kcl.ac.uk.

ABSTRACT
Low income countries like Ethiopia are underrepresented in clinical research. As a major public commitment to clinical research, Ethiopia celebrated the International Clinical Trial Day (ICTD) for the first time on 20 May 2014 under the auspices of Addis Ababa University. The motto for the day was 'Clinical Trials for Excellence in Patient Care'. The celebration offered an opportunity to inform academic staff, researchers, students and the leadership about clinical trials being conducted and to discuss the future of clinical trials in the country. Although clear challenges to the conduct of trials abound, clinical trials registered from Ethiopia in trial registration databases is increasing. Cross-country collaborations, international funding support, motivation of academic staff to conduct clinical trials and the commitment and engagement of the leadership in research are all improving. The overall impact of clinical trials is also encouraging. For example, some of the trials conducted in Ethiopia have informed treatment guidelines. However, administrative capacity, research infrastructure as well as financial support remain weak. There is a need for enhanced university-industry linkage and translation of research findings into locally relevant evidence. Ethiopia, as well as the whole of Africa, has an unparalleled opportunity to lead the way in clinical trials, given its prospect of development and the need to have locally relevant evidence for its growing population. In this commentary we reflect on the celebration of ICTD, the status and opportunities for conducting clinical trials and the way forward for facilitating clinical trials in Ethiopia and Africa.

Show MeSH